The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Cardiovascular Surgery Devices And Equipment Market During The Forecast Period?
The cardiovascular surgery devices and equipment market size has observed modest expansion in recent years. It is projected to increase from $1.8 billion in 2025 to $1.82 billion in 2026, reflecting a compound annual growth rate (CAGR) of 0.7%. Historically, this growth can be attributed to several factors including an increasing incidence of cardiovascular disorders, the broadening of cardiac surgery procedures, the availability of advanced surgical equipment, the proliferation of specialized cardiac hospitals, and the rising adoption of bypass and ablation systems.
The cardiovascular surgery devices and equipment market size is projected to experience consistent expansion over the upcoming years. This market is predicted to reach a value of $2.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.1%. Factors contributing to this growth throughout the forecast period include a rising need for less invasive heart procedures, increased funding for advanced surgical technologies, the proliferation of hybrid cardiac operating theaters, the expanding application of AI-powered surgical planning, and ongoing advancements in cardiovascular surgical instruments. Key trends anticipated during the forecast period encompass a greater uptake of minimally invasive cardiac surgery tools, an increased application of advanced cardiac ablation methods, improved accuracy in cardiopulmonary bypass systems, the broadening use of beating heart surgery approaches, and a stronger emphasis on enhancing surgical results.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp
Which Important Drivers Are Guiding The Cardiovascular Surgery Devices And Equipment Market Growth?
The increasing elderly demographic is anticipated to stimulate expansion in the cardiovascular surgical devices market in the future. The term geriatric population denotes individuals aged 65 years and older, recognized as older adults within a populace. These individuals typically exhibit greater healthcare demands, stemming from physiological alterations linked to aging and a higher incidence of chronic ailments. Cardiovascular surgical devices provide assistance to the geriatric population by facilitating safer, less invasive procedures that treat heart conditions associated with aging, thereby enhancing overall survival rates and life quality. For example, by October 2025, as reported by the World Health Organization, a Switzerland-based intergovernmental organization, projections indicate that from 2020 to 2050, the population aged 80 years of age or older is predicted to treble to 426 million. Consequently, the expanding geriatric population is a key factor propelling the development of the cardiovascular surgical devices market.
What Segment Categories Shape The Cardiovascular Surgery Devices And Equipment Market Segment Landscape?
The cardiovascular surgery devices and equipment market covered in this report is segmented –
1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Ambulatory Surgical Centers, Hospitals, Cardiac Specialty Centers, Research Laboratories
Subsegments:
1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices
2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment
3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices
4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables
What Trends Are Influencing The Evolution Of The Cardiovascular Surgery Devices And Equipment Market?
Major corporations are channelling investments into businesses within the cardiovascular surgery devices and Equipment market that are dedicated to creating innovative solutions, such as CardioVisio for Atrial Fibrillation (AFib). These efforts aim to enhance early diagnosis, improve patient outcomes, and streamline treatment procedures. CardioVisio for Atrial Fibrillation (AFib) is an advanced diagnostic and monitoring tool developed to detect and manage AFib, a common form of irregular heart rhythm. As an illustration, in August 2023, GE HealthCare, a US-based medical technology firm, introduced CardioVisio for Atrial Fibrillation (AFib), a digital clinical decision support system designed to improve precision care for patients with AFib. This pioneering solution, unveiled at the ESC Congress 2023, incorporates longitudinal patient data from various sources to provide clinicians with a comprehensive insight into heart health. By delivering evidence-based recommendations consistent with AFib guidelines, CardioVisio optimizes clinical workflows and enhances adherence to best practices.
Who Are The Companies Operating Across The Cardiovascular Surgery Devices And Equipment Market Value Chain?
Major companies operating in the cardiovascular surgery devices and equipment market are Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., TransMedics, Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Medtronic plc, Cyberheart Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.p.A., Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., LivaNova PLC, CryoLife Inc., Artivion Inc.
Get The Full Cardiovascular Surgery Devices And Equipment Market Report:
Which Region Represents The Largest Share Of The Cardiovascular Surgery Devices And Equipment Market?
North America was the largest region in the global cardiovascular surgery devices and equipment market in 2025. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cardiovascular Surgery Devices And Equipment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp
Browse Through More Reports Similar to the Global Cardiovascular Surgery Devices And Equipment Market 2026, By The Business Research Company
Cosmetic Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/cosmetic-implants-global-market-report
Smart Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-implants-global-market-report
Dental Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/dental-implants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model